Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry

Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry

Aim. To evaluate the acute myeloid leukemia (AML) treatment efficacy in adults in Moscow real clinical practice according to the Moscow Cancer Registry data.Materials and methods. We retrospectively collected data from the Moscow Cancer Registry on Moscow permanent residents who were primary diagnos...

Full description

Saved in:
Bibliographic Details
Main Authors: T. N. Tolstykh, E. N. Misyurina, M. A. Mingalimov, E. A. Baryakh, E. I. Zhelnova, D. E. Gagloeva, S. A. Kardovskaya, T. S. Chudnova, E. N. Zotina, D. D. Ivanova, O.  L. Kochneva, K. V. Yatskov, L. T. Shimanovskaya, D. S. Mar’in, A. B. Makeshova, N. G. Chernova, G. A. Dudina, M. A. Granatkin, T. A. Semina, A. V. Misyurin, M. A. Lysenko
Format: Article
Language:Russian
Published: ABV-press 2024-09-01
Series:Онкогематология
Subjects:
acute myeloid leukemia
efficacy of antitumor therapy
targeted therapy
allogeneic hematopoietic stem cell transplantation
real clinical practice
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/941
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://oncohematology.abvpress.ru/ongm/article/view/941

Similar Items